By John K. Waters
Stand Up to Cancer (SU2C) has announced a partnership with technology firm SandboxAQ aimed at accelerating the development of cancer treatments through advanced artificial intelligence tools.
Read Now
By John K. Waters
SIME Diagnostics, a UK-based medical technology firm, has completed a clinical study evaluating an artificial intelligence-powered Lung Maturity Test (LMT) designed to identify respiratory risks in late-preterm newborns in the United States.
Read Now
By John K. Waters
OpenAI launches HealthBench, a massive new benchmark that's the company's first major independent health care project.
Read Now
By John K. Waters
Life sciences software company ACTO has announced an upcoming release of its next-generation Life Sciences AI Conversational Assistant (LAICA), aimed at improving information access and interaction quality for pharmaceutical field teams.
Read Now
By John K. Waters
Global medical technology firm BD (Becton, Dickinson and Company) has launched a new cell analysis instrument that combines two advanced technologies—spectral flow cytometry and real-time cell imaging—into a single platform, aiming to expand the range of cell-based experiments in biomedical research.
Read Now
By John K. Waters
Minnesota-based medtech firm iotaMotion has announced the first use of its iotaSOFT Insertion System outside the United States as part of a pre-market clinical investigation at the University Hospital of Zurich in Switzerland.
Read Now
By John K. Waters
AI and quantum computing company SandboxAQ has announced a new collaboration with NVIDIA aimed at accelerating breakthroughs in drug development, therapeutic design, and medical imaging through the deployment of a new AI platform built on NVIDIA's DGX Cloud infrastructure.
Read Now
By John K. Waters
Voice AI company Deepgram has unveiled Nova 3 Medical, a next-generation speech-to-text model built specifically for the healthcare sector, claiming it delivers the most accurate real-time medical transcription on the market.
Read Now
By John K. Waters
PDS Health announces the launch of PDS Health Technologies, a new division aimed at extending its data-driven care infrastructure and expanding access to integrated electronic health record (EHR) solutions across a broader network of providers.
Read Now
By John K. Waters
The global market for nanotechnology in medical devices is set for significant growth, driven by technological advancements, increasing healthcare demands, and a shift towards precision medicine. According to a newly released report by Research And Markets, the sector was valued at $3.4 billion in 2024 and is projected to reach $4.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4%.
Read Now